We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-10.61%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$845M
AUM Growth
-$125M
Cap. Flow
-$13.7M
Cap. Flow %
-1.62%
Top 10 Hldgs %
30.78%
Holding
184
New
1
Increased
38
Reduced
77
Closed
19

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$18.4M
2
CB icon
Chubb
CB
+$2.56M
3
RTX icon
RTX Corp
RTX
+$1.98M
4
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$1.84M
5
TRMB icon
Trimble
TRMB
+$1.38M

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$19.1M
2
COL
Rockwell Collins
COL
+$8.66M
3
WPP icon
WPP
WPP
+$7.11M
4
T icon
AT&T
T
+$2.18M
5
XRAY icon
Dentsply Sirona
XRAY
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 18.38%
3 Financials 12.05%
4 Consumer Staples 11.36%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$640B
$12.7M 1.5%
98,353
-1,933
-2% -$270K
USB icon
27
US Bancorp
USB
$97.9B
$12.4M 1.47%
272,176
+13,044
+5% +$671K
SNY icon
28
Sanofi
SNY
$107B
$12.4M 1.47%
285,764
+2,290
+0.8% +$101K
UN
29
DELISTED
Unilever NV New York Registry Shares
UN
$11.9M 1.41%
220,723
-1,434
-0.6% -$78.3K
RDS.B
30
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$11.7M 1.39%
195,392
+13,081
+7% +$836K
WY icon
31
Weyerhaeuser
WY
$17.6B
$11.6M 1.37%
529,032
+42,103
+9% +$1.12M
CB icon
32
Chubb
CB
$140B
$11.5M 1.36%
89,179
+19,833
+29% +$2.56M
NVS icon
33
Novartis
NVS
$302B
$10.7M 1.26%
138,564
-273
-0.2% -$21.3K
EBAY icon
34
eBay
EBAY
$51.2B
$10.2M 1.21%
363,997
+19,495
+6% +$573K
GLW icon
35
Corning
GLW
$107B
$9.89M 1.17%
327,255
-5,226
-2% -$167K
CVX icon
36
Chevron
CVX
$382B
$9.74M 1.15%
89,493
+1,046
+1% +$121K
GILD icon
37
Gilead Sciences
GILD
$165B
$9.47M 1.12%
151,430
-605
-0.4% -$42.3K
TRMB icon
38
Trimble
TRMB
$13.6B
$9.31M 1.1%
282,759
+37,461
+15% +$1.38M
BC icon
39
Brunswick
BC
$5.23B
$9.14M 1.08%
196,798
+4,698
+2% +$251K
SNPS icon
40
Synopsys
SNPS
$71.6B
$9.13M 1.08%
108,331
-2,003
-2% -$178K
UL icon
41
Unilever
UL
$142B
$8.6M 1.02%
146,248
+1,140
+0.8% +$68.7K
PPG icon
42
PPG Industries
PPG
$24.9B
$8.59M 1.02%
84,032
+5,082
+6% +$526K
ALB icon
43
Albemarle
ALB
$13.4B
$8.38M 0.99%
108,730
+7,525
+7% +$710K
AMAT icon
44
Applied Materials
AMAT
$347B
$7.9M 0.93%
241,302
-717
-0.3% -$24.6K
CTSH icon
45
Cognizant
CTSH
$26.5B
$7.55M 0.89%
118,923
+5,908
+5% +$411K
FLIR
46
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$6.83M 0.81%
156,768
+37,440
+31% +$1.84M
BRK.A icon
47
Berkshire Hathaway Class A
BRK.A
$1.1T
$6.73M 0.8%
22
-1
-4% -$313K
AMGN icon
48
Amgen
AMGN
$209B
$6.47M 0.77%
33,238
-1,044
-3% -$204K
TMO icon
49
Thermo Fisher Scientific
TMO
$214B
$5.91M 0.7%
26,396
-478
-2% -$112K
MDLZ icon
50
Mondelez International
MDLZ
$83.4B
$5.76M 0.68%
143,828
-302
-0.2% -$12.9K

Similar funds

Grandfield & Dodd's Q4 2018 Portfolio in Review

As of Q4 2018, Grandfield & Dodd held 184 positions worth $845M, down 13% from $970M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q4 2018 filing shows 1 new, 38 increased, 77 reduced and 19 closed positions. Its largest new stake was Linde: 116,658 shares worth $18.2M. The largest sale was Praxair Inc, an estimated $19.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q4 2018 buy was Linde: 116,658 shares worth $18.2M.
  • Grandfield & Dodd added most to Chubb in Q4 2018, an estimated $2.56M increase.
  • Grandfield & Dodd's biggest Q4 2018 reduction was WPP, cutting an estimated $7.11M.
  • Grandfield & Dodd fully exited Praxair Inc in Q4 2018, selling an estimated $19.1M.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $845M portfolio in Q4 2018.
  • Grandfield & Dodd opened 1 new position and closed 19 in Q4 2018.
  • Grandfield & Dodd's portfolio value fell 13% quarter-over-quarter to $845M.

Based on Grandfield & Dodd's 13F filing for Q4 2018, filed 12 Feb 2019.